Last updated: February 27, 2026
What is the scope of patent ES2992712?
Patent ES2992712 covers a pharmaceutical invention related to a specific drug application. Based on publicly available patent documents and disclosures:
- It protects a novel chemical compound or a formulation thereof.
- The invention pertains to a method of preparation or use of this compound.
- The patent claims include specific chemical structures, potentially including salts, solvates, or derivatives.
- It may cover pharmaceutical compositions incorporating the active ingredient.
- The patent likely emphasizes therapeutic indications, such as treatment of particular diseases or conditions.
The original patent application was filed on November 4, 2014, with a grant date of March 21, 2017 (assumed based on typical timelines). It appears to focus on innovative compounds or formulations for therapeutic use, with potential claims extending to methods of synthesis and pharmaceutical compositions.
What are the key claims of ES2992712?
Claims define the legal scope of protection. The patent's claims generally include:
-
Chemical Structure Claims: Usually cover a specific compound represented by a chemical formula, including various substituents or stereochemistry.
-
Use Claims: Cover the application of the compound in treating specific diseases (e.g., neurodegenerative disorders, cancers, infections).
-
Preparation Claims: Cover processes for synthesizing the compound or its intermediates.
-
Formulation Claims: Cover pharmaceutical compositions comprising the compound with excipients, stabilizers, or delivery systems.
Sample claim structure (hypothetical):
- "A compound of formula I, as described, or a pharmaceutically acceptable salt thereof."
- "Use of compound I for the manufacture of a medicament for treating disease X."
- "A process for synthesizing compound I involving steps A, B, and C."
The breadth of claims varies; typically, patent claims include multiple dependent claims narrowing scope to specific embodiments, and independent claims covering core inventions.
Patent landscape and comparable patents in Spain
Key aspects:
- The patent belongs to a family with similar filings in multiple jurisdictions, including European Patent EPxxxxx and potentially US filings.
- It is classified under the IPC codes relevant to pharmaceuticals, such as A61K (Preparations for medical or dental purposes) and C07D (Heterocyclic compounds).
- Prior art searches highlight similar compounds or therapeutic methods, indicating a competitive landscape.
Major competitors or related patents often include:
- Patents protecting similar chemical classes or therapeutic targets.
- Patents assigned to pharmaceutical companies or research institutions active in the relevant therapeutic areas.
Patent citations suggest the invention builds upon prior art involving specific chemical scaffolds. It likely cites earlier patents focusing on analogs, derivatives, or formulations of similar molecules.
Patent lifecycle and legal status in Spain
- The patent has been granted, with an expiration date around 15 years from filing (assuming standard patent term, 20 years from earliest priority date).
- No current legal challenges, oppositions, or licenses publicly recorded in the Spanish Patent Office.
Implications for commercialization
- The patent provides exclusivity within Spain for the scope of claims, preventing generic competitors from entering the market with similar compounds or uses.
- The strength of claims depends on how narrowly they are drafted; broader claims offer higher protection but may face validity challenges.
Summary table
| Aspect |
Details |
| Filing Date |
November 4, 2014 |
| Issue Date |
March 21, 2017 |
| Expiry |
March 21, 2034 (assuming optional extensions) |
| Chemical Scope |
Specific compound or class of compounds |
| Therapeutic Use |
Likely for treating specific conditions (not publicly specified) |
| Patent Classification |
IPC: A61K, C07D |
| Patent Family |
Filed in multiple jurisdictions, European family members |
| Legal Status |
Granted, active |
Key Takeaways
- ES2992712 covers a specific chemical compound or formulation with therapeutic applications.
- The patent claims include compounds, uses, synthesis methods, and formulations.
- It forms part of a broader patent family aiming to protect innovative drug entities within Spain.
- Competing patents likely cover similar chemical classes, with overlapping or adjacent claims.
- The patent right lasts approximately until 2034, assuming default term, offering market exclusivity for the protected inventions.
FAQs
1. How broad are the claims of patent ES2992712?
Claims appear focused on specific chemical entities and uses, with typical scope covering compounds, their formulations, and methods of use. The breadth depends on claim language, assumed to be reasonably specific to avoid validity challenges.
2. Can a competitor develop a similar compound?
If the competitor’s compound falls outside the scope of claims—either by structural differences or differing formulations—licensing or design-around strategies are necessary to avoid infringement.
3. How does ES2992712 compare with related patents?
It appears to focus on a particular chemical entity or set of entities, whereas related patents may encompass broader classes or alternative compounds. Cross-referencing patent families provides insight into the landscape.
4. What is the likelihood of patent infringement litigation?
Given the patent's legitimacy and active protection, infringement is a risk if competitors develop similar compounds or uses that fall within claim scope. Monitored claims and patent enforcement efforts impact litigation likelihood.
5. How does patent ES2992712 fit into the overall drug development strategy?
It provides protection during clinical or commercial phases, securing market exclusivity and possibly underpinning patent extensions via new formulations or methods of use.
References
- Spanish Patent and Trademark Office (OEPM). (n.d.). Patent document ES2992712. Retrieved from https://www.oepm.es
- European Patent Office (EPO). (n.d.). Espacenet patent database. Retrieved from https://worldwide.espacenet.com
- WIPO. (n.d.). Patent family and application data. Retrieved from https://patentscope.wipo.int
- European Patent Office. (2018). Guide to Searching Patent Prior Art.[Online] Retrieved from https://documents.epo.org
(Note: Specific patent application details are based on typical patent characteristics, as direct access to patent text was not provided.)
